AI Generated
Aug 16, 2026, 16:13
Juveriya Shaik: Awareness Study on Menstrual Delay Tablets and Risk of DVT
Juveriya Shaik, Bachelor of Pharmacy Graduate at Dr. Samuel George Institute of Pharmaceutical Sciences, shared a post on LinkedIn:
“Academic Project – Awareness Study on Menstrual Delay Tablets and Risk of Deep Vein Thrombosis (DVT)
Conducted an awareness study among women aged 18–45 years to assess knowledge regarding the safe use of menstrual delay tablets and the associated risk of DVT.
112 respondents participated in this community-based study.
This project enhanced my understanding of pharmaceutical research, patient awareness, data collection, and medication safety.”
Stay updated with Hemostasis Today.
-
Aug 17, 2026, 17:03Ahmad Hazri Mohamed Aris: Strengthening Hemophilia Care in Fiji
-
Aug 17, 2026, 16:56Suspicion-Based Screening for Occult Malignancy in Lower Extremity Venous Thrombosis – JTH
-
Aug 17, 2026, 16:51Kathaleen Schnur: Celebrating The Bleeding Disorders Community
-
Aug 17, 2026, 16:45Eugenio Caradonna: Can Light Replace Chemicals in PRP Activation?
-
Aug 17, 2026, 16:30Jeff Sternlicht: We Don’t Measure Lp(a) Because We Have a Drug
-
Aug 17, 2026, 16:22Francesca Palandri: Why Is Ruxolitinib Response So Heterogeneous in Myelofibrosis?
-
Aug 17, 2026, 15:22Antoine Francis: The Hidden Power of Albumin
-
Aug 17, 2026, 15:13Gabriela A.: New FDA Approval Advances the Future of Dried Plasma
-
Aug 17, 2026, 15:01Alan Dursun: When Haemophilia Care Becomes a Reality